296 related articles for article (PubMed ID: 33687887)
1. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics.
Advani D; Sharma S; Kumari S; Ambasta RK; Kumar P
Anticancer Agents Med Chem; 2022; 22(3):433-468. PubMed ID: 33687887
[TBL] [Abstract][Full Text] [Related]
2. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
3. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics.
Collins DC; Sundar R; Lim JSJ; Yap TA
Trends Pharmacol Sci; 2017 Jan; 38(1):25-40. PubMed ID: 27871777
[TBL] [Abstract][Full Text] [Related]
4. The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy.
Low SK; Nakamura Y
Jpn J Clin Oncol; 2019 Jul; 49(7):596-603. PubMed ID: 31135897
[TBL] [Abstract][Full Text] [Related]
5. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in cancer immunology and immunology-based anticancer therapies.
Kumar S; Saini RV; Mahindroo N
Biomed Pharmacother; 2017 Dec; 96():1491-1500. PubMed ID: 29198747
[TBL] [Abstract][Full Text] [Related]
7. Overview of precision oncology trials: challenges and opportunities.
Fountzilas E; Tsimberidou AM
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):797-804. PubMed ID: 30044653
[TBL] [Abstract][Full Text] [Related]
8. Immunoengineering through cancer vaccines - A personalized and multi-step vaccine approach towards precise cancer immunity.
Lybaert L; Vermaelen K; De Geest BG; Nuhn L
J Control Release; 2018 Nov; 289():125-145. PubMed ID: 30223044
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of artificial intelligence in cancer drug development and precision therapy.
Liang G; Fan W; Luo H; Zhu X
Biomed Pharmacother; 2020 Aug; 128():110255. PubMed ID: 32446113
[TBL] [Abstract][Full Text] [Related]
10. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
Bashraheel SS; Domling A; Goda SK
Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
[TBL] [Abstract][Full Text] [Related]
11. Applications of artificial intelligence multiomics in precision oncology.
Srivastava R
J Cancer Res Clin Oncol; 2023 Jan; 149(1):503-510. PubMed ID: 35796775
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
13. Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines.
Solomon BJ; Beavis PA; Darcy PK
Am Soc Clin Oncol Educ Book; 2020 May; 40():1-6. PubMed ID: 32412805
[TBL] [Abstract][Full Text] [Related]
14. The Future of Precision Oncology.
Rulten SL; Grose RP; Gatz SA; Jones JL; Cameron AJM
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628794
[TBL] [Abstract][Full Text] [Related]
15. Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.
Bendjama K; Quemeneur E
Hum Vaccin Immunother; 2017 Sep; 13(9):1997-2003. PubMed ID: 28846477
[TBL] [Abstract][Full Text] [Related]
16. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
Subbiah V; Kurzrock R
Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
[TBL] [Abstract][Full Text] [Related]
17. Application of immune repertoire sequencing in cancer immunotherapy.
Zhuang Y; Zhang C; Wu Q; Zhang J; Ye Z; Qian Q
Int Immunopharmacol; 2019 Sep; 74():105688. PubMed ID: 31276974
[TBL] [Abstract][Full Text] [Related]
18. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomics in personalized cancer treatments.
Kiyotani K; Toyoshima Y; Nakamura Y
J Hum Genet; 2021 Sep; 66(9):901-907. PubMed ID: 34193979
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
